USPTO serial 79328756
Serial No. 79328756
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 7, 2023
- Examiner
- JONES, JACQUELYN ANDREA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79328756?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products, namely, chemical test kits for DNA and RNA isolation and rRNA depletion kits containing buffers and reagents for use in industry and science; Chemical reagents other than for medical or veterinary purposes for purifying and analyzing samples for use in the fields of molecular biology, chemistry, biochemistry, drug discovery, pharmacology, toxicology, molecular pathology, disease research, genomics and proteomics; chemical, biochemical and biotechnological substances for industrial and scientific purposes, namely, polypeptides and proteins for use in connection with molecular biological applications for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment; chemical, biochemical and biotechnological preparations for diagnostic and scientific purposes, laboratory reagents for scientific use and diagnostic reagents for clinical or medical laboratory use, all the aforesaid goods, in particular for the treatment and purification of samples of human, animal and plant cells and tissues and samples of microorganisms and of extracts therefrom and not for medical or veterinary purposes; diagnostic reagents for in vitro use in clinical chemistry; enzymes for scientific and research purposes, not for medical or veterinary purposes, in particular for use in kits and for use in carrying out DNA labeling, DNA replication, DNA analysis or RNA labeling, RNA replication, RNA analysis and for enzyme preparation | ACTIVE | — |
| 005 | Veterinary products, namely, veterinary diagnostic reagents; pharmaceutical preparations, namely, nucleic acid molecules for medical and veterinary purposes, for use in determining genotypes, profiling biopolymer, detecting disease, determining disease progression, and determining responses to drugs; diagnostic reagents for medical use in diagnosing inflammation, infection, central nervous system diseases, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, and cancer, comprised of reagents, processing chemicals and nucleic acid molecules; medical diagnostic test kits composed of medical diagnostic reagents for the detection of pathogens in the environment; clinical medical reagents and diagnostic reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic test kits composed of medical diagnostic reagents to identify, quantify and analyze dna or rna; reagents and enzymes for performing dna or rna analyzes for medical purposes | ACTIVE | — |
| 009 | Scientific apparatus, instruments and devices, namely, conductivity meters and ultra-high vacuum chambers for research and diagnostic purposes; downloadable software, for data analysis; downloadable software for the analysis of bioinformatic data, sequence data on fragmented sequence information, for pcr analysis and for next generation sequencing; chromatography columns for scientific or laboratory use; all the aforesaid goods for industrial and scientific purposes, in particular for molecular biological purposes for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment or for the purification of these molecules, and for reagent kits for industrial and scientific purposes, in particular for DNA (deoxyribonucleic acid) treatment, RNA (ribonucleic acid) treatment and protein treatment or purification of these molecules; laboratory equipment, in particular automated microfluidic and macrofluidic devices for the isolation, preparation, marking, replication or screening of genetic material or RNA or proteins | ACTIVE | — |
| 042 | Services in connection with scientific research and development, namely, scientific research consulting and scientific study in the field of research, development and diagnostics, and engineering, computer software, graphic design services in this field; scientific and technological services, namely, scientific analysis in the field of research, development and diagnostics relating to genomics, transcriptomics, proteomics and genetic engineering; design of pharmaceutical and medical diagnostic products and biochemical and biotechnological preparations relating to genomics, transcriptomics, proteomics and genetic engineering; scientific and technological services, namely, scientific research, development, diagnostics and analysis in the field of diagnostic chemicals and reagents, sorting of nucleotides, separation processes and purification processes, chemical screening analyzes and conducting diagnostic, forensic and genetic-medical tests for others; scientific research and development for others in the field of diagnostic chemical agents and reagents for use as diagnostic, therapeutic preparations and chemical screening and diagnostics for others; conducting quality control tests and quality control of scientific analyzes for others relating to nucleic acids; scientific analysis of nucleic acids, in particular for detection purposes; scientific and technological services, namely, scientific research, analysis and testing in the field of DNA for the treatment of nucleic acids and proteins, in particular separation, purification, isolation, labeling and amplification of the aforesaid molecules; development of software, in particular development of software for data analysis, for the analysis of bioinformatic data, sequence data and fragmented sequence information, and development of software for pcr analysis and next generation sequencing; scientific analysis of bioinformatic data, sequence data and fragmented sequence information, especially in the context of next generation sequencing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lexogen GmbH
- Other trademarks owned by Lexogen GmbH
- Other trademarks owned by Lexogen GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 10, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 10, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 7, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 21, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 20, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 20, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 30, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 30, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 10, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 10, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 10, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 10, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 10, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 7, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 6, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |